What Knip makes
Knip is a women-led biotechnology company that develops nutritional solutions for animal feed. Its social media handles link it to KnipBio, and its chief scientific officer holds the same title at KnipBio. The company’s product is JUV, an all-natural fermented ingredient that it adds to existing feeds. The site targets aquaculture and also has a section on companion animals.
JUV is positioned as a protein-rich package that boosts feed rather than replaces it. Knip says it improves juvenile survival, stress resilience and recovery, and raises farm profitability, based on more than 50 trials across species. The page describes the dried powder as a high-protein delivery system for bioactive compounds, so a feed formulator should request the protein analysis.
The company belongs to the family of microbial biomass ingredients described under single-cell protein. Unlike products sold mainly as a protein source in bulk, JUV is sold for functional effect at low inclusion, which changes how it is priced, dosed and evaluated. A buyer should compare it with feed additives and functional ingredients rather than only with fishmeal and soy.
Organism and fermentation
The science page says JUV comes from a proprietary leaf microbe, a naturally occurring organism found on plants such as oak trees and lettuce. Knip says it found the bacterium after years of searching in the wild and that it can upcycle agricultural by-products. The species name is not given, so ask for its identity and safety dossier.
Production is described as a simple fermentation in large commercial-scale bioreactors, followed by drying. The powder is designed to blend into existing feed formulas and extrusion processes. Extrusion tolerance matters because heat and shear can damage sensitive compounds, so ask for retention data of the actives after extrusion at your temperatures.
The company says the microbe produces non-pigmenting carotenoids, antioxidants and anti-inflammatory compounds, and acts as a prebiotic supporting gut health. These descriptions point to a mode of action based on bioactives, not on amino acid supply. A buyer should ask which compounds are measured in each lot, with what method, and whether the specification includes minimum levels.
Trial results
Knip reports trial figures. In shrimp, survival in a controlled disease challenge rose from 25 to 75 percent, and in a Thailand farm demonstration from 20 to 60 percent. In salmonids, survival after a stress event rose from 70 to 85 percent, harvest biomass by up to 21 percent and gross margin by up to 28 percent.
An infectious hematopoietic necrosis trial is described in more detail. Fish fed JUV showed milder symptoms, delayed mortality by about eight days and had a 63 percent increase in survival, with normal appetite, growth and feed conversion. After a move from an indoor nursery to an outdoor raceway, fed fish kept their feeding response while controls recovered more slowly.
The company also cites more than a dozen feeding trials with research organisations and whitepapers on reduced mortality in hatcheries and early grow-out, including Litopenaeus vannamei. These outcomes are company-reported. A buyer should ask for trial protocols, replicates, statistics and any peer-reviewed publication, and then run a trial on its own stock.
How a buyer would evaluate Knip
Start with the economics. Ask for the inclusion rate, price per tonne of finished feed and expected return based on survival and growth. The company states a cost of goods fall of 11 percent per kilogram in salmonids, but this depends on feed price, species and baseline mortality, so it should be recalculated with your own farm data.
Check regulatory status by market. Feed additives need approval or listing in many jurisdictions, and a microbial biomass may be classed as a feed ingredient or as an additive with claims. Ask which markets accept the product, which category applies, which label claims are permitted and whether the organism has been assessed for safety.
Finally, assess supply and quality. Request the production site, the capacity of the bioreactors, lead time and a certificate of analysis for each lot. Ask about heavy metals, mycotoxins and microbial limits, shelf life under tropical storage, and the company’s change notification policy. A trial lot and a written trial design with success criteria is a sensible first step.